Judith Goslin Hall

From WikiMD's WELLNESSPEDIA

Judith Goslin Hall (born 1939) is a Canadian pediatrician and geneticist. She is a professor emerita of Pediatrics and Medical Genetics at the University of British Columbia. Hall is known for her work on human congenital anomalies including neurofibromatosis, Turner syndrome, Arthrogryposis, and RASopathies.

Early life and education[edit]

Hall was born in 1939 in New York City. She completed her undergraduate degree at Wellesley College in 1960 and her medical degree at the University of Washington in 1964. She completed her pediatric residency at the Children's Hospital Boston and her genetics fellowship at the University of Washington.

Career[edit]

Hall started her career at the University of British Columbia (UBC) in 1970. She served as the Head of the Department of Pediatrics from 1985 to 1992 and the Head of the Division of Medical Genetics from 1993 to 2001. She retired in 2004 and was named a professor emerita.

Research[edit]

Hall's research focuses on human congenital anomalies including neurofibromatosis, Turner syndrome, arthrogryposis, and RASopathies. She has published over 300 peer-reviewed articles and has co-authored two books.

Awards and honors[edit]

Hall has received numerous awards and honors for her work. She was elected to the National Academy of Medicine in 1998 and the Royal Society of Canada in 2001. She received the Order of British Columbia in 2016 and the Order of Canada in 2017.

References[edit]


External links[edit]

  • Judith G. Hall at the University of British Columbia



Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.